58602-844-66 : NDC 2025 Code

58602-844-66 : Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride ( Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride )

Additionally :

You can get information about “58602-844-66” NDC code in 58602-844-66 in HTML format

HTML | 58602-844-66 in TXT (Plain Text) format

TXT | 58602-844-66 in PDF (Portable Document Format)

PDF | 58602-844-66 in XML format

XML formats.

NDC Code : 58602-844-66 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "58602-844-66",
    "PackageDescription": "2 BLISTER PACK in 1 CARTON (58602-844-66)  / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK",
    "NDC11Code": "58602-0844-66",
    "ProductNDC": "58602-844",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride",
    "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250417",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA215232",
    "LabelerName": "Aurohealth LLC",
    "SubstanceName": "FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "StrengthNumber": "180; 240",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-04-24",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250417",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}